You are here: Industry Insights > patents

News List

University of California Granted Two New U.S. CRISPR-Cas9 Patents americanpharmaceuticalreview
July 24, 2019
The U.S. Patent and Trademark Office (USPTO) has awarded two new patents to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of the CRISPR-Cas9 gene-editing technology.
MEDICREA secures several new patents to protect UNiD ASI biospectrumasia
June 18, 2019
Over the last few years, MEDICREA has had a leading role in revolutionizing personalized spine surgery.
Micell Technologies Announces Expanded Patent Estate prnasia
March 21, 2018
Micell Technologies Announces Expanded Patent Estate-PR Newswire Asia
Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars Tang
December 27, 2017
The Chinese biosimilar market can reach RMB 20-30 billion in 2020...
Volition Granted Four Additional Patents prnasia
September 15, 2017
Dr. Jake Micallef, Chief Scientific Officer of Volition, commented, "Our worldwide portfolio of granted patents that protects various aspects of Volition's Nu.QTM technology is growing.
Starpharma sells crop chemical business to Agrium for $26m biospectrumasia
June 15, 2017
The acquisition is comprised of key patents, technical know-how, and a small number of staff based in Melbourne
MPEG LA invites CRISPR-Cas9 patents to be pooled in a one-stop license biospectrumasia
May 03, 2017
Accessibility to a multi-user market will maximize CRISPR’s life-enhancing potential
RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA® b3cnewswire
April 19, 2017
RedHill received Notices of Allowance from the United States Patent and Trademark Office (USPTO) for two new patents covering BEKINDA® (RHB-102), expected to be valid until at least 2034, once granted
Eagle Pharmaceuticals Announces Three New Patents Issued for Bendeka americanpharmaceuticalreview
March 23, 2017
Eagle Pharmaceuticals, Inc. has announced that three additional patents have been issued related to Bendeka by the United States Patent and Trademark Office (USPTO).
$100 billion of revenues up for grabs for drug manufacturers as patents for key biologics expire cphi-online
March 17, 2017
For success in the biosimilars sector, manufacturers must adopt QbD, DoE and PAT initiatives.

Previous page 1 2 Next page